Category: Diabetes

Global pharma company Lupin announced the acquisition of Huminsulin in India from Eli Lilly and Company (Lilly), aiming to expand its diabetes …

These innovations significantly improve patient adherence and diabetes management. Despite its potential, the market faces challenges, including the …

Doha, Qatar: The 25th Al Bawasil Children with Diabetes Camp, organized by Diabetes Qatar, a member of Qatar Foundation, recently came to a close.

It’s time to take …

Diabetic wounds are extremely difficult to heal due to the long duration and high recurrence rate. The bacterial infection caused by elevated …

Blood sugar control is a priority for anyone at risk of diabetes, but sometimes glucose creeps up despite a person’s best efforts.

… diabetes (GD), according to a study published online Dec. 19 in JAMA Network Open. Wanglong Gou, Ph.D., from Westlake Laboratory of Life Sciences …

Highlighting the challenges faced by students with type 1 diabetes during examinations, a call has been made to the Union Minister of Education, …

… diabetes — about 30 per cent lower — and smaller, but notable reductions, in risks of hypertension and dyslipidemia (abnormal lipid levels in blood)

The FDA issued a Complete Response Letter for sotagliflozin in type 1 diabetes with chronic kidney disease, citing risk-benefit concerns.

Diabetes management has come a long way, with diabetes drugs evolving from basic insulin therapies to innovative medications targeting specific …

Oxygen treatment reduced cell activity but did not improve metabolic function in patients with diabetes. Date: December 18, 2024; Source: University …